1-4 of 4
Joanna Leal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Daratumumab (Dara), Cyclophosphamide, Thalidomide and Dexamethasone for Transplant Eligible Newly Diagnosed Multiple Myeloma (TE NDMM) Patients: Response Rate Impacts on PFS

Edvan De Queiroz Crusoe, Joanna Leal, Juliana Andrade Santos, Herbert Henrique de Melo Santos, Allan de souza Santos, Larissa Ferreira Lucas, Alessandro de M. Almeida, Marcos Chaves, Daniela Dourado Dutra, Vania T.M. Hungria, Marco Aurelio Salvino, Maria da Gloria B. Arruda
Journal: Blood
Blood (2022) 140 (Supplement 1): 7699–7700.
https://doi.org/10.1182/blood-2022-164866
Published: 2022
Journal Articles

Progression Free Survival (PFS) Analysis of Daratumumab (Dara), Cyclophosphamide, Thalidomide and Dexamethasone: A Quadruplet Intensified Treatment for Transplant Eligible Newly Diagnosed Multiple Myeloma (TE NDMM) Patients

Edvan De Queiroz Crusoe, Joanna Leal, Marco Aurelio Salvino, Larissa Ferreira Lucas, Juliana Andrade Santos, Herbert Henrique de Melo Santos, Alessandro de M. Almeida, Allan de souza Santos, Marcos Chaves, Mariane Melo Santos, Sarah Queiroz Silva, Lucas de Oliveira Vieira, Cleverson Alves Fonseca, Elisangela Adorno, Vania Hungria, Maria da Gloria B. Arruda
Journal: Blood
Blood (2021) 138 (Supplement 1): 3943.
https://doi.org/10.1182/blood-2021-150607
Published: 2021
Journal Articles

Evaluation of Hematopoietic Stem Cell Product As a New Site for Minimal Residual Disease By Next Generation Flow in Multiple Myeloma

Herbert Henrique de Melo Santos, Glaciano Ribeiro, Allan de souza Santos, Marcos Chaves, Joanna Leal, Juliana Andrade Santos, Alessandro de M. Almeida, Marco Aurelio Salvino, Mariane Melo Santos, Vania Hungria, Maria da Gloria B. Arruda, Edvan De Queiroz Crusoe
Journal: Blood
Blood (2021) 138 (Supplement 1): 4927.
https://doi.org/10.1182/blood-2021-154129
Published: 2021
Journal Articles

Preliminary Results of Daratumumab, Cyclophosphamide, Thalidomide and Dexamethasone: A Quadruplet Intensified Treatment for Newly Diagnosed Multiple Myeloma (NDMM) Transplant Eligible (TE) Patients

Edvan De Queiroz Crusoe, MDPhD, Marco Aurelio Salvino, MD PhD, Sarah Queiroz Silva, MD, Herbert Henrique de Melo Santos, MD, Allan de souza Santos, BS, Alessandro de M. Almeida, MD, Lucas de Oliveira Vieira, MD, Cleverson Alves Fonseca, Pham, Larissa Ferreira Lucas, MD, Joanna Leal, MD, Mariane Melo Santos, BS, MsC, Juliana Andrade Santos, MD, Elisangela Adorno, Pham, PhD, Vania T. M. Hungria, MD PhD, Maria da Gloria B. Arruda, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-138873
Published: 2020